NCT06864598View on ClinicalTrials.gov

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

Enrolling by invitationOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

October 31, 2026

Conditions

Graft-versus-host Disease (GVHD)

Trial Locations (1)

100035

No. 11 Xizhimen South Street, Xicheng District, Beijing, China, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER